Nexentis Technologies Inc. , through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects.
Nexentis Technologies stock last closed at $2.29, up 0% from the previous day, and has decreased 96.38% in one year. It has underperformed other stocks in the Agricultural Inputs industry by 0.93 percentage points. Nexentis Technologies stock is currently +8.02% from its 52-week low of $2.12, and -97.45% from its 52-week high of $89.79.
There are currently 730,459 shares of NXTS outstanding. The market value of NXTS is $1.67M. In the last 24 hours, 24,000 NXTS shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy NXTS shares.
Based on our analysis, eToro is the best stock brokerage. Here's why:
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, it's time to fill out some personal info so you can buy NXTS stock today.
Now that you have finished signing up on the best stock buying app, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help transferring funds into your new brokerage account.
After you have figured out the best place to buy Nexentis Technologies stock, it's important to analyze their stock before you invest, so you actually wrap your head around the risk as well as the upside.
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on NXTS's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NXTS's true value.
Using relative valuations measures:
You can access additional valuation research on NXTS's stock here.
Over the last year, executives and large shareholders at NXTS have sold more shares than they have bought.
Eun Young Lee, 10% Owner of NXTS, was the latest NXTS insider to sell. They sold $172.09 worth of NXTS stock on Jan 29, 2026.
Get more info about who owns NXTS shares here.
No, Nexentis Technologies doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main order types:
Press the Open Trade button and your broker will execute the order.
If you require additional info about buying stocks on eToro, click the how to video below:
Now that you own some shares in NXTS, you'll want to stay up-to-date on your investment.
Make a watchlist to get alerted to the latest events about your NXTS stock.
To reiterate, here are the 6 steps for buying Nexentis Technologies stock:
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Nexentis Technologies, click the button below.